Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Depression 2Unipolar Major Depression 1Radiation Injuries 1Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Depressive Disorder, Major 1

Interventions

Therapeutics 31Psychiatric Rehabilitation 27Surveys and Questionnaires 15Cognitive Behavioral Therapy 12Early Intervention, Educational 10Psilocybin 9Ketamine 9Methods 8Saline Solution 7Yoga 6Mindfulness-Based Cognitive Therapy 6Interviews as Topic 6Esketamine 6Counseling 6Psychosocial Intervention 5Mindfulness 5Methylphenidate 5Escitalopram 5Educational Status 5Behavior Therapy 5Acupuncture Therapy 5Palliative Care 4Exercise Therapy 4Exercise 4Control Groups 4Caregivers 4Standard of Care 3Psychotherapy 3Niacin 3Mindfulness-Based Stress Reduction 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Depression × Vortioxetine × Clear all
NCT04818099 2021-03-26

Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase 3 Unknown
208 enrolled
Head & Neck

Depression, Head and Neck Neoplasms, Radiation Injuries

NCT04253678 2020-02-05

Vortioxetine for Cancer Patients With Depression: An Observational Study

University of Malaya

Unknown
140 enrolled

Depression, Depressive Disorder, Major, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡